Brief: Coeptis Therapeutics S-4 Declared Effective By SEC
06/01/2026 14:11
Jan 6 (Reuters) - Coeptis Therapeutics Holdings Inc COEP.O: COEPTIS THERAPEUTICS S-4 DECLARED EFFECTIVE BY SEC, PROXY MAILING BEGINS IN ANTICIPATION OF THE MERGER TRANSACTION WITH Z SQUARED Source text: ID:nGNX2WkVKs Further company coverage: COEP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Z Squared (Delaware)
See all newsBrief: Z Squared Inc. Signs Definitive Agreement To Acquire 100% Of Paradox Data And Its Union County Campus
Brief: Z Squared, Inc. To Acquire Majority Interest In Paradox Data And Its Union County Campus, A Next-Generation Data Center Development Targeting Up To 150 MW Of Firm Power
Brief: Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement To Support Ai Infrastructure Buildout
Brief: Z Squared Appoints Jon Najarian, Pete Najarian, Marc Lopresti And Jay Zapata To Newly Formed Advisory Board
Brief: Z Squared Announces Executive Leadership Appointments To Advance Ai Infrastructure Strategy